TY - JOUR
T1 - Post-Transplantation Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplantation: Results of the Prospective Randomized HOVON-96 Trial in Recipients of Matched Related and Unrelated Donors
AU - de Jong, Cornelis N.
AU - Meijer, Ellen
AU - Bakunina, Katerina
AU - Nur, Erfan
AU - van Marwijk Kooij, Marinus
AU - de Groot, Marco R.
AU - van Gelder, Michel
AU - Maertens, Johan A.
AU - Kuball, Jurgen H. E.
AU - Deeren, Dries
AU - van der Holt, Bronno
AU - Cornelissen, Jan J.
AU - Broers, Annoek E. C.
PY - 2019
Y1 - 2019
N2 - DISCLOSURES: Nur: Novartis Pharmaceuticals: Consultancy. Maertens:Cidara: Other: Personal fees and non-financial support; Gilead Sciences: Other: Grants, personal fees and non-financial support; Amplyx: Other: Personal fees and non-financial support; Merck: Other: Personal fees and non-financial support; Pfizer: Other: Grant and personal fees; Astellas Pharma: Other: Personal fees and non-financial support; F2G: Other: Personal fees and non-financial support. Deeren:Alexion, Amgen, Janssen, Roche, Sunesis, Takeda, Sanofi: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding.
AB - DISCLOSURES: Nur: Novartis Pharmaceuticals: Consultancy. Maertens:Cidara: Other: Personal fees and non-financial support; Gilead Sciences: Other: Grants, personal fees and non-financial support; Amplyx: Other: Personal fees and non-financial support; Merck: Other: Personal fees and non-financial support; Pfizer: Other: Grant and personal fees; Astellas Pharma: Other: Personal fees and non-financial support; F2G: Other: Personal fees and non-financial support. Deeren:Alexion, Amgen, Janssen, Roche, Sunesis, Takeda, Sanofi: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074960800&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/31723985
U2 - https://doi.org/10.1182/blood-2019-124659
DO - https://doi.org/10.1182/blood-2019-124659
M3 - Article
C2 - 31723985
SN - 0006-4971
VL - 134
SP - 1
JO - Blood
JF - Blood
IS - 1
ER -